New, Highly Sensitive PCR-based COVID-19 Assay Utilizes Switch-Blocker PCR Technology
Biocept, Inc. (San Diego, CA, USA) and Aegea Biotechnologies, Inc. (San Diego, CA, USA) have entered into an agreement to develop a COVID-19 PCR assay based on the core Switch-Blocker technology used in Biocept's suite of ultra-sensitive oncology-focused assays. More...10 Aug 2020
AI Helps Find Alternative Pharmaceutical Building Blocks for 12 Drugs under Investigation to Treat COVID-19
A team of medicinal chemists at the University of Michigan (Ann Arbor, MI, USA) have used artificial intelligence (AI) to find alternative pharmaceutical building blocks for 12 drugs under investigation to treat COVID-19. More...10 Aug 2020
Eurofins Launches Reagents for Automated Extraction of Genomic SARS-CoV-2 RNA from Clinical Swab Samples
Eurofins Technologies (Luxembourg) has launched reagents for automated isolation of high-quality SARS-CoV-2 RNA (ribonucleic acid) from viral particles of human respiratory specimens. More...10 Aug 2020
Vela Diagnostics' ViroKey SARS-CoV-2 RT-PCR Test Granted FDA Emergency Use Authorization
Vela Diagnostics (Singapore) has obtained Emergency Use Authorization from the US Food and Drug Administration (FDA) for the manual version of its probe-based reverse transcription PCR test that detects SARS-CoV-2. More...10 Aug 2020
UK Government to Roll Out Millions of 90 Minute COVID-19 Test Kits from DnaNudge and Oxford Nanopore
The UK government has placed orders for millions of high-speed COVID-19 test kits from DnaNudge (London, UK) and Oxford Nanopore Technologies (Oxford, UK) to be used in NHS hospitals from September. More...06 Aug 2020
No-Touch, Paper-Based COVID-19 Diagnostic Test Could Detect SARS-CoV-2 Using Electrical Frequencies
Researchers from the Iowa State University (Ames, IA, USA) are developing a closed, contact-free diagnostic sensing system that could be used to quickly test for COVID-19 or other outbreaks. More...06 Aug 2020
Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
New
Diagnostic Ultrasound System
MS1700C
New
Hospital Data Analytics Software
OR Companion
In Other News
NIH Clinical Trial to Evaluate Antibodies and Experimental Therapeutics for COVID-19
Eurofins Clinical Diagnostics Launches Lower Cost Highly Accurate COVID-19 PCR Test
Johnson & Johnson to Supply US Government with 100 Million Doses of Investigational COVID-19 Vaccine
Thermo Fisher Launches New High-Throughput, Fully Automated, Real-Time PCR Solution for COVID-19 Testing
Novavax COVID-19 Vaccine Elicits Wild-Type Virus Neutralizing Antibody Responses in 100% of Participants in Phase 1/2 Trial
BioNTech Begins Phase 1 Trial of mRNA-based COVID-19 Vaccine Candidate with Fosun Pharma in China
Bio-Techne and Mount Sinai Launch Kantaro Quantitative SARS-CoV-2 IgG Antibody RUO Kit
FDA Could Issue Emergency Use Authorization for COVID-19 Vaccine Within Weeks After Clinical Trial Data Meet Efficacy Requirements
Quidel Receives NIH Funding to Accelerate Capacity Expansion for Manufacturing Sofia SARS-CoV-2 Antigen Detection Test
Snibe Diagnostic’s Maglumi SARS-CoV-2 S-RBD IgG Test Receives CE Mark
First Molecular T Cell Monitoring Tool for SARS-CoV-2 Launched
Potential Medical Solution Utilizes Nanobody Technology for Detection and Treatment of COVID-19
Regeneron’s COVID-19 Antibody Drug Cocktail Completely Blocks Coronavirus Infection in Animal Test
Mammoth Biosciences’ CRISPR SARS-CoV-2 Diagnostic Platform Becomes First CRISPR-Based Initiative to Be Funded by NIH
Slight Variability in Coronavirus Mutations Could Make COVID-19 Vaccine Effective Against All SARS-CoV-2 Strains
Imperial College Begins Immunizing Hundreds of People with Experimental COVID-19 Vaccine in Early Trial
COVID-19 Vaccine Could Give Immunity for At Least 12 Months, Says AstraZeneca
Rapid COVID-19 Test Uses Graphene-Enhanced Sensor to Produce Signal After Positively Identifying Viral Antigens
Researchers Testing Do-It-Yourself COVID-19 Vaccine on Themselves
Eli Lilly Begins Phase 3 Trial of Human Antibody LY-CoV555 for Prevention of COVID-19
First FDA EUA COVID-19 Saliva Testing Kits Launched
Pfizer and BioNTech to Supply Japan with 120 Million Doses of mRNA-Based COVID-19 Vaccine
Applied DNA’s COVID-19 Diagnostic Kit Granted FDA EUA Amendment for Use on Widely Installed RT-PCR Device and High-Throughput RNA Extraction Robotics
